nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—SLC6A2—Clonidine—glaucoma	0.0615	0.102	CbGbCtD
Fluoxetine—CYP2D6—Carteolol—glaucoma	0.0498	0.0827	CbGbCtD
Fluoxetine—CYP1A2—Betaxolol—glaucoma	0.0408	0.0678	CbGbCtD
Fluoxetine—CYP2D6—Betaxolol—glaucoma	0.0337	0.0559	CbGbCtD
Fluoxetine—CYP2C19—Methazolamide—glaucoma	0.0335	0.0557	CbGbCtD
Fluoxetine—CYP2C9—Diclofenamide—glaucoma	0.0324	0.0538	CbGbCtD
Fluoxetine—CYP2C9—Dorzolamide—glaucoma	0.0313	0.052	CbGbCtD
Fluoxetine—CYP3A5—Clonidine—glaucoma	0.0301	0.0499	CbGbCtD
Fluoxetine—CYP2C19—Timolol—glaucoma	0.0285	0.0474	CbGbCtD
Fluoxetine—CYP2C9—Methazolamide—glaucoma	0.0279	0.0463	CbGbCtD
Fluoxetine—CYP2D6—Methazolamide—glaucoma	0.0255	0.0424	CbGbCtD
Fluoxetine—CYP3A4—Pilocarpine—glaucoma	0.024	0.0399	CbGbCtD
Fluoxetine—ABCB1—Timolol—glaucoma	0.023	0.0382	CbGbCtD
Fluoxetine—CYP1A2—Clonidine—glaucoma	0.0224	0.0372	CbGbCtD
Fluoxetine—CYP2D6—Timolol—glaucoma	0.0217	0.036	CbGbCtD
Fluoxetine—ABCB1—Clonidine—glaucoma	0.0196	0.0325	CbGbCtD
Fluoxetine—CYP3A4—Brinzolamide—glaucoma	0.0188	0.0313	CbGbCtD
Fluoxetine—CYP2D6—Clonidine—glaucoma	0.0184	0.0306	CbGbCtD
Fluoxetine—CYP3A4—Dorzolamide—glaucoma	0.0182	0.0302	CbGbCtD
Fluoxetine—CYP3A4—Methazolamide—glaucoma	0.0162	0.0269	CbGbCtD
Fluoxetine—CYP3A4—Acetazolamide—glaucoma	0.013	0.0215	CbGbCtD
Fluoxetine—CYP3A4—Clonidine—glaucoma	0.0117	0.0195	CbGbCtD
Fluoxetine—Pruritus—Bimatoprost—glaucoma	0.000116	0.000328	CcSEcCtD
Fluoxetine—Diarrhoea—Apraclonidine—glaucoma	0.000116	0.000327	CcSEcCtD
Fluoxetine—Malaise—Clonidine—glaucoma	0.000116	0.000327	CcSEcCtD
Fluoxetine—Dyspepsia—Pilocarpine—glaucoma	0.000115	0.000326	CcSEcCtD
Fluoxetine—Chills—Betaxolol—glaucoma	0.000115	0.000325	CcSEcCtD
Fluoxetine—Syncope—Clonidine—glaucoma	0.000115	0.000325	CcSEcCtD
Fluoxetine—Arrhythmia—Betaxolol—glaucoma	0.000115	0.000324	CcSEcCtD
Fluoxetine—Feeling abnormal—Dorzolamide—glaucoma	0.000114	0.000323	CcSEcCtD
Fluoxetine—Decreased appetite—Pilocarpine—glaucoma	0.000114	0.000322	CcSEcCtD
Fluoxetine—Feeling abnormal—Travoprost—glaucoma	0.000114	0.000321	CcSEcCtD
Fluoxetine—Conjunctivitis—Timolol—glaucoma	0.000114	0.00032	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000113	0.00032	CcSEcCtD
Fluoxetine—Alopecia—Betaxolol—glaucoma	0.000113	0.00032	CcSEcCtD
Fluoxetine—Palpitations—Clonidine—glaucoma	0.000113	0.00032	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000113	0.00032	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Travoprost—glaucoma	0.000113	0.000319	CcSEcCtD
Fluoxetine—Loss of consciousness—Clonidine—glaucoma	0.000113	0.000318	CcSEcCtD
Fluoxetine—Feeling abnormal—Brinzolamide—glaucoma	0.000112	0.000317	CcSEcCtD
Fluoxetine—Mental disorder—Betaxolol—glaucoma	0.000112	0.000317	CcSEcCtD
Fluoxetine—Pain—Pilocarpine—glaucoma	0.000112	0.000316	CcSEcCtD
Fluoxetine—Constipation—Pilocarpine—glaucoma	0.000112	0.000316	CcSEcCtD
Fluoxetine—Cough—Clonidine—glaucoma	0.000112	0.000316	CcSEcCtD
Fluoxetine—Sweating—Timolol—glaucoma	0.000112	0.000316	CcSEcCtD
Fluoxetine—Dizziness—Apraclonidine—glaucoma	0.000112	0.000316	CcSEcCtD
Fluoxetine—Malnutrition—Betaxolol—glaucoma	0.000112	0.000315	CcSEcCtD
Fluoxetine—Urticaria—Dorzolamide—glaucoma	0.00011	0.000311	CcSEcCtD
Fluoxetine—Epistaxis—Timolol—glaucoma	0.00011	0.000311	CcSEcCtD
Fluoxetine—Body temperature increased—Dorzolamide—glaucoma	0.00011	0.00031	CcSEcCtD
Fluoxetine—Abdominal pain—Dorzolamide—glaucoma	0.00011	0.00031	CcSEcCtD
Fluoxetine—Tension—Betaxolol—glaucoma	0.00011	0.000309	CcSEcCtD
Fluoxetine—Sinusitis—Timolol—glaucoma	0.00011	0.000309	CcSEcCtD
Fluoxetine—Dysgeusia—Betaxolol—glaucoma	0.000109	0.000309	CcSEcCtD
Fluoxetine—Chest pain—Clonidine—glaucoma	0.000109	0.000308	CcSEcCtD
Fluoxetine—Arthralgia—Clonidine—glaucoma	0.000109	0.000308	CcSEcCtD
Fluoxetine—Abdominal pain—Travoprost—glaucoma	0.000109	0.000308	CcSEcCtD
Fluoxetine—Anxiety—Clonidine—glaucoma	0.000109	0.000307	CcSEcCtD
Fluoxetine—Asthenia—Acetazolamide—glaucoma	0.000109	0.000307	CcSEcCtD
Fluoxetine—Dizziness—Bimatoprost—glaucoma	0.000109	0.000306	CcSEcCtD
Fluoxetine—Nervousness—Betaxolol—glaucoma	0.000109	0.000306	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000108	0.000306	CcSEcCtD
Fluoxetine—Urticaria—Brinzolamide—glaucoma	0.000108	0.000306	CcSEcCtD
Fluoxetine—Feeling abnormal—Pilocarpine—glaucoma	0.000108	0.000305	CcSEcCtD
Fluoxetine—Discomfort—Clonidine—glaucoma	0.000108	0.000305	CcSEcCtD
Fluoxetine—Vomiting—Apraclonidine—glaucoma	0.000108	0.000304	CcSEcCtD
Fluoxetine—Muscle spasms—Betaxolol—glaucoma	0.000107	0.000303	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000107	0.000303	CcSEcCtD
Fluoxetine—Hypersensitivity—Brimonidine—glaucoma	0.000107	0.000302	CcSEcCtD
Fluoxetine—Dry mouth—Clonidine—glaucoma	0.000107	0.000302	CcSEcCtD
Fluoxetine—Bradycardia—Timolol—glaucoma	0.000107	0.000301	CcSEcCtD
Fluoxetine—Dermatitis—Apraclonidine—glaucoma	0.000107	0.000301	CcSEcCtD
Fluoxetine—Headache—Apraclonidine—glaucoma	0.000106	0.000299	CcSEcCtD
Fluoxetine—Confusional state—Clonidine—glaucoma	0.000106	0.000298	CcSEcCtD
Fluoxetine—Rhinitis—Timolol—glaucoma	0.000105	0.000297	CcSEcCtD
Fluoxetine—Tremor—Betaxolol—glaucoma	0.000105	0.000295	CcSEcCtD
Fluoxetine—Hallucination—Timolol—glaucoma	0.000104	0.000294	CcSEcCtD
Fluoxetine—Asthenia—Brimonidine—glaucoma	0.000104	0.000294	CcSEcCtD
Fluoxetine—Infection—Clonidine—glaucoma	0.000104	0.000294	CcSEcCtD
Fluoxetine—Body temperature increased—Pilocarpine—glaucoma	0.000104	0.000293	CcSEcCtD
Fluoxetine—Abdominal pain—Pilocarpine—glaucoma	0.000104	0.000293	CcSEcCtD
Fluoxetine—Ill-defined disorder—Betaxolol—glaucoma	0.000104	0.000293	CcSEcCtD
Fluoxetine—Diarrhoea—Acetazolamide—glaucoma	0.000104	0.000292	CcSEcCtD
Fluoxetine—Rash—Bimatoprost—glaucoma	0.000103	0.000292	CcSEcCtD
Fluoxetine—Dermatitis—Bimatoprost—glaucoma	0.000103	0.000292	CcSEcCtD
Fluoxetine—Oedema peripheral—Timolol—glaucoma	0.000103	0.000291	CcSEcCtD
Fluoxetine—Anaemia—Betaxolol—glaucoma	0.000103	0.000291	CcSEcCtD
Fluoxetine—Shock—Clonidine—glaucoma	0.000103	0.000291	CcSEcCtD
Fluoxetine—Pruritus—Brimonidine—glaucoma	0.000103	0.00029	CcSEcCtD
Fluoxetine—Headache—Bimatoprost—glaucoma	0.000103	0.00029	CcSEcCtD
Fluoxetine—Thrombocytopenia—Clonidine—glaucoma	0.000103	0.000289	CcSEcCtD
Fluoxetine—Hypersensitivity—Dorzolamide—glaucoma	0.000102	0.000289	CcSEcCtD
Fluoxetine—Tachycardia—Clonidine—glaucoma	0.000102	0.000288	CcSEcCtD
Fluoxetine—Hypersensitivity—Travoprost—glaucoma	0.000102	0.000287	CcSEcCtD
Fluoxetine—Skin disorder—Clonidine—glaucoma	0.000102	0.000287	CcSEcCtD
Fluoxetine—Hyperhidrosis—Clonidine—glaucoma	0.000101	0.000286	CcSEcCtD
Fluoxetine—Visual impairment—Timolol—glaucoma	0.000101	0.000285	CcSEcCtD
Fluoxetine—Malaise—Betaxolol—glaucoma	0.000101	0.000284	CcSEcCtD
Fluoxetine—Nausea—Apraclonidine—glaucoma	0.000101	0.000284	CcSEcCtD
Fluoxetine—Hypersensitivity—Brinzolamide—glaucoma	0.000101	0.000284	CcSEcCtD
Fluoxetine—Vertigo—Betaxolol—glaucoma	0.0001	0.000283	CcSEcCtD
Fluoxetine—Syncope—Betaxolol—glaucoma	0.0001	0.000283	CcSEcCtD
Fluoxetine—Dizziness—Acetazolamide—glaucoma	0.0001	0.000283	CcSEcCtD
Fluoxetine—Anorexia—Clonidine—glaucoma	9.98e-05	0.000282	CcSEcCtD
Fluoxetine—Asthenia—Dorzolamide—glaucoma	9.96e-05	0.000281	CcSEcCtD
Fluoxetine—Asthenia—Travoprost—glaucoma	9.91e-05	0.00028	CcSEcCtD
Fluoxetine—Palpitations—Betaxolol—glaucoma	9.87e-05	0.000279	CcSEcCtD
Fluoxetine—Pruritus—Dorzolamide—glaucoma	9.82e-05	0.000277	CcSEcCtD
Fluoxetine—Loss of consciousness—Betaxolol—glaucoma	9.82e-05	0.000277	CcSEcCtD
Fluoxetine—Asthenia—Brinzolamide—glaucoma	9.79e-05	0.000276	CcSEcCtD
Fluoxetine—Hypotension—Clonidine—glaucoma	9.79e-05	0.000276	CcSEcCtD
Fluoxetine—Pruritus—Travoprost—glaucoma	9.78e-05	0.000276	CcSEcCtD
Fluoxetine—Tinnitus—Timolol—glaucoma	9.78e-05	0.000276	CcSEcCtD
Fluoxetine—Cough—Betaxolol—glaucoma	9.75e-05	0.000275	CcSEcCtD
Fluoxetine—Nausea—Bimatoprost—glaucoma	9.75e-05	0.000275	CcSEcCtD
Fluoxetine—Hypersensitivity—Pilocarpine—glaucoma	9.66e-05	0.000273	CcSEcCtD
Fluoxetine—Pruritus—Brinzolamide—glaucoma	9.65e-05	0.000272	CcSEcCtD
Fluoxetine—Vomiting—Acetazolamide—glaucoma	9.63e-05	0.000272	CcSEcCtD
Fluoxetine—Dizziness—Brimonidine—glaucoma	9.61e-05	0.000271	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Clonidine—glaucoma	9.54e-05	0.000269	CcSEcCtD
Fluoxetine—Myalgia—Betaxolol—glaucoma	9.51e-05	0.000268	CcSEcCtD
Fluoxetine—Chest pain—Betaxolol—glaucoma	9.51e-05	0.000268	CcSEcCtD
Fluoxetine—Arthralgia—Betaxolol—glaucoma	9.51e-05	0.000268	CcSEcCtD
Fluoxetine—Diarrhoea—Dorzolamide—glaucoma	9.5e-05	0.000268	CcSEcCtD
Fluoxetine—Headache—Acetazolamide—glaucoma	9.49e-05	0.000268	CcSEcCtD
Fluoxetine—Anxiety—Betaxolol—glaucoma	9.48e-05	0.000267	CcSEcCtD
Fluoxetine—Insomnia—Clonidine—glaucoma	9.47e-05	0.000267	CcSEcCtD
Fluoxetine—Diarrhoea—Travoprost—glaucoma	9.46e-05	0.000267	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	9.45e-05	0.000267	CcSEcCtD
Fluoxetine—Asthenia—Pilocarpine—glaucoma	9.41e-05	0.000266	CcSEcCtD
Fluoxetine—Paraesthesia—Clonidine—glaucoma	9.4e-05	0.000265	CcSEcCtD
Fluoxetine—Discomfort—Betaxolol—glaucoma	9.4e-05	0.000265	CcSEcCtD
Fluoxetine—Arrhythmia—Timolol—glaucoma	9.37e-05	0.000264	CcSEcCtD
Fluoxetine—Dyspnoea—Clonidine—glaucoma	9.34e-05	0.000263	CcSEcCtD
Fluoxetine—Diarrhoea—Brinzolamide—glaucoma	9.34e-05	0.000263	CcSEcCtD
Fluoxetine—Somnolence—Clonidine—glaucoma	9.31e-05	0.000263	CcSEcCtD
Fluoxetine—Dry mouth—Betaxolol—glaucoma	9.3e-05	0.000263	CcSEcCtD
Fluoxetine—Pruritus—Pilocarpine—glaucoma	9.28e-05	0.000262	CcSEcCtD
Fluoxetine—Alopecia—Timolol—glaucoma	9.26e-05	0.000261	CcSEcCtD
Fluoxetine—Confusional state—Betaxolol—glaucoma	9.19e-05	0.000259	CcSEcCtD
Fluoxetine—Mental disorder—Timolol—glaucoma	9.19e-05	0.000259	CcSEcCtD
Fluoxetine—Dizziness—Dorzolamide—glaucoma	9.18e-05	0.000259	CcSEcCtD
Fluoxetine—Rash—Brimonidine—glaucoma	9.16e-05	0.000259	CcSEcCtD
Fluoxetine—Dermatitis—Brimonidine—glaucoma	9.15e-05	0.000258	CcSEcCtD
Fluoxetine—Dizziness—Travoprost—glaucoma	9.14e-05	0.000258	CcSEcCtD
Fluoxetine—Malnutrition—Timolol—glaucoma	9.13e-05	0.000258	CcSEcCtD
Fluoxetine—Headache—Brimonidine—glaucoma	9.1e-05	0.000257	CcSEcCtD
Fluoxetine—Decreased appetite—Clonidine—glaucoma	9.1e-05	0.000257	CcSEcCtD
Fluoxetine—Infection—Betaxolol—glaucoma	9.06e-05	0.000256	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Clonidine—glaucoma	9.04e-05	0.000255	CcSEcCtD
Fluoxetine—Fatigue—Clonidine—glaucoma	9.03e-05	0.000255	CcSEcCtD
Fluoxetine—Dizziness—Brinzolamide—glaucoma	9.02e-05	0.000255	CcSEcCtD
Fluoxetine—Nausea—Acetazolamide—glaucoma	8.99e-05	0.000254	CcSEcCtD
Fluoxetine—Diarrhoea—Pilocarpine—glaucoma	8.97e-05	0.000253	CcSEcCtD
Fluoxetine—Shock—Betaxolol—glaucoma	8.97e-05	0.000253	CcSEcCtD
Fluoxetine—Tension—Timolol—glaucoma	8.96e-05	0.000253	CcSEcCtD
Fluoxetine—Constipation—Clonidine—glaucoma	8.96e-05	0.000253	CcSEcCtD
Fluoxetine—Pain—Clonidine—glaucoma	8.96e-05	0.000253	CcSEcCtD
Fluoxetine—Dysgeusia—Timolol—glaucoma	8.94e-05	0.000252	CcSEcCtD
Fluoxetine—Thrombocytopenia—Betaxolol—glaucoma	8.93e-05	0.000252	CcSEcCtD
Fluoxetine—Tachycardia—Betaxolol—glaucoma	8.9e-05	0.000251	CcSEcCtD
Fluoxetine—Nervousness—Timolol—glaucoma	8.86e-05	0.00025	CcSEcCtD
Fluoxetine—Skin disorder—Betaxolol—glaucoma	8.86e-05	0.00025	CcSEcCtD
Fluoxetine—Vomiting—Dorzolamide—glaucoma	8.82e-05	0.000249	CcSEcCtD
Fluoxetine—Hyperhidrosis—Betaxolol—glaucoma	8.81e-05	0.000249	CcSEcCtD
Fluoxetine—Rash—Dorzolamide—glaucoma	8.75e-05	0.000247	CcSEcCtD
Fluoxetine—Dermatitis—Dorzolamide—glaucoma	8.74e-05	0.000247	CcSEcCtD
Fluoxetine—Rash—Travoprost—glaucoma	8.71e-05	0.000246	CcSEcCtD
Fluoxetine—Dermatitis—Travoprost—glaucoma	8.71e-05	0.000246	CcSEcCtD
Fluoxetine—Headache—Dorzolamide—glaucoma	8.69e-05	0.000245	CcSEcCtD
Fluoxetine—Anorexia—Betaxolol—glaucoma	8.69e-05	0.000245	CcSEcCtD
Fluoxetine—Vomiting—Brinzolamide—glaucoma	8.68e-05	0.000245	CcSEcCtD
Fluoxetine—Dizziness—Pilocarpine—glaucoma	8.67e-05	0.000245	CcSEcCtD
Fluoxetine—Headache—Travoprost—glaucoma	8.66e-05	0.000244	CcSEcCtD
Fluoxetine—Nausea—Brimonidine—glaucoma	8.63e-05	0.000244	CcSEcCtD
Fluoxetine—Feeling abnormal—Clonidine—glaucoma	8.63e-05	0.000244	CcSEcCtD
Fluoxetine—Rash—Brinzolamide—glaucoma	8.6e-05	0.000243	CcSEcCtD
Fluoxetine—Dermatitis—Brinzolamide—glaucoma	8.6e-05	0.000243	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Clonidine—glaucoma	8.56e-05	0.000242	CcSEcCtD
Fluoxetine—Headache—Brinzolamide—glaucoma	8.55e-05	0.000241	CcSEcCtD
Fluoxetine—Hypotension—Betaxolol—glaucoma	8.52e-05	0.00024	CcSEcCtD
Fluoxetine—Angioedema—Timolol—glaucoma	8.34e-05	0.000235	CcSEcCtD
Fluoxetine—Vomiting—Pilocarpine—glaucoma	8.34e-05	0.000235	CcSEcCtD
Fluoxetine—Urticaria—Clonidine—glaucoma	8.32e-05	0.000235	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Betaxolol—glaucoma	8.31e-05	0.000234	CcSEcCtD
Fluoxetine—Abdominal pain—Clonidine—glaucoma	8.28e-05	0.000234	CcSEcCtD
Fluoxetine—Body temperature increased—Clonidine—glaucoma	8.28e-05	0.000234	CcSEcCtD
Fluoxetine—Rash—Pilocarpine—glaucoma	8.27e-05	0.000233	CcSEcCtD
Fluoxetine—Dermatitis—Pilocarpine—glaucoma	8.26e-05	0.000233	CcSEcCtD
Fluoxetine—Insomnia—Betaxolol—glaucoma	8.25e-05	0.000233	CcSEcCtD
Fluoxetine—Nausea—Dorzolamide—glaucoma	8.24e-05	0.000233	CcSEcCtD
Fluoxetine—Headache—Pilocarpine—glaucoma	8.22e-05	0.000232	CcSEcCtD
Fluoxetine—Nausea—Travoprost—glaucoma	8.21e-05	0.000232	CcSEcCtD
Fluoxetine—Vertigo—Timolol—glaucoma	8.2e-05	0.000231	CcSEcCtD
Fluoxetine—Paraesthesia—Betaxolol—glaucoma	8.19e-05	0.000231	CcSEcCtD
Fluoxetine—Syncope—Timolol—glaucoma	8.18e-05	0.000231	CcSEcCtD
Fluoxetine—Dyspnoea—Betaxolol—glaucoma	8.13e-05	0.000229	CcSEcCtD
Fluoxetine—Nausea—Brinzolamide—glaucoma	8.1e-05	0.000229	CcSEcCtD
Fluoxetine—Palpitations—Timolol—glaucoma	8.07e-05	0.000228	CcSEcCtD
Fluoxetine—Dyspepsia—Betaxolol—glaucoma	8.03e-05	0.000226	CcSEcCtD
Fluoxetine—Loss of consciousness—Timolol—glaucoma	8.02e-05	0.000226	CcSEcCtD
Fluoxetine—Cough—Timolol—glaucoma	7.96e-05	0.000225	CcSEcCtD
Fluoxetine—Decreased appetite—Betaxolol—glaucoma	7.93e-05	0.000224	CcSEcCtD
Fluoxetine—Hypertension—Timolol—glaucoma	7.88e-05	0.000222	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Betaxolol—glaucoma	7.87e-05	0.000222	CcSEcCtD
Fluoxetine—Fatigue—Betaxolol—glaucoma	7.86e-05	0.000222	CcSEcCtD
Fluoxetine—Pain—Betaxolol—glaucoma	7.8e-05	0.00022	CcSEcCtD
Fluoxetine—Constipation—Betaxolol—glaucoma	7.8e-05	0.00022	CcSEcCtD
Fluoxetine—Nausea—Pilocarpine—glaucoma	7.79e-05	0.00022	CcSEcCtD
Fluoxetine—Chest pain—Timolol—glaucoma	7.77e-05	0.000219	CcSEcCtD
Fluoxetine—Arthralgia—Timolol—glaucoma	7.77e-05	0.000219	CcSEcCtD
Fluoxetine—Myalgia—Timolol—glaucoma	7.77e-05	0.000219	CcSEcCtD
Fluoxetine—Anxiety—Timolol—glaucoma	7.74e-05	0.000219	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	7.72e-05	0.000218	CcSEcCtD
Fluoxetine—Hypersensitivity—Clonidine—glaucoma	7.72e-05	0.000218	CcSEcCtD
Fluoxetine—Discomfort—Timolol—glaucoma	7.68e-05	0.000217	CcSEcCtD
Fluoxetine—Dry mouth—Timolol—glaucoma	7.6e-05	0.000214	CcSEcCtD
Fluoxetine—Asthenia—Clonidine—glaucoma	7.51e-05	0.000212	CcSEcCtD
Fluoxetine—Feeling abnormal—Betaxolol—glaucoma	7.51e-05	0.000212	CcSEcCtD
Fluoxetine—Confusional state—Timolol—glaucoma	7.51e-05	0.000212	CcSEcCtD
Fluoxetine—Anaphylactic shock—Timolol—glaucoma	7.45e-05	0.00021	CcSEcCtD
Fluoxetine—Pruritus—Clonidine—glaucoma	7.41e-05	0.000209	CcSEcCtD
Fluoxetine—Infection—Timolol—glaucoma	7.4e-05	0.000209	CcSEcCtD
Fluoxetine—Shock—Timolol—glaucoma	7.33e-05	0.000207	CcSEcCtD
Fluoxetine—Urticaria—Betaxolol—glaucoma	7.24e-05	0.000204	CcSEcCtD
Fluoxetine—Skin disorder—Timolol—glaucoma	7.24e-05	0.000204	CcSEcCtD
Fluoxetine—Body temperature increased—Betaxolol—glaucoma	7.21e-05	0.000203	CcSEcCtD
Fluoxetine—Hyperhidrosis—Timolol—glaucoma	7.2e-05	0.000203	CcSEcCtD
Fluoxetine—Diarrhoea—Clonidine—glaucoma	7.17e-05	0.000202	CcSEcCtD
Fluoxetine—Anorexia—Timolol—glaucoma	7.1e-05	0.0002	CcSEcCtD
Fluoxetine—Hypotension—Timolol—glaucoma	6.96e-05	0.000196	CcSEcCtD
Fluoxetine—Dizziness—Clonidine—glaucoma	6.93e-05	0.000195	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Timolol—glaucoma	6.79e-05	0.000192	CcSEcCtD
Fluoxetine—Insomnia—Timolol—glaucoma	6.74e-05	0.00019	CcSEcCtD
Fluoxetine—Hypersensitivity—Betaxolol—glaucoma	6.72e-05	0.00019	CcSEcCtD
Fluoxetine—Paraesthesia—Timolol—glaucoma	6.69e-05	0.000189	CcSEcCtD
Fluoxetine—Vomiting—Clonidine—glaucoma	6.66e-05	0.000188	CcSEcCtD
Fluoxetine—Dyspnoea—Timolol—glaucoma	6.64e-05	0.000187	CcSEcCtD
Fluoxetine—Somnolence—Timolol—glaucoma	6.62e-05	0.000187	CcSEcCtD
Fluoxetine—Rash—Clonidine—glaucoma	6.6e-05	0.000186	CcSEcCtD
Fluoxetine—Dermatitis—Clonidine—glaucoma	6.6e-05	0.000186	CcSEcCtD
Fluoxetine—Headache—Clonidine—glaucoma	6.56e-05	0.000185	CcSEcCtD
Fluoxetine—Dyspepsia—Timolol—glaucoma	6.56e-05	0.000185	CcSEcCtD
Fluoxetine—Asthenia—Betaxolol—glaucoma	6.54e-05	0.000185	CcSEcCtD
Fluoxetine—Decreased appetite—Timolol—glaucoma	6.48e-05	0.000183	CcSEcCtD
Fluoxetine—Pruritus—Betaxolol—glaucoma	6.45e-05	0.000182	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Timolol—glaucoma	6.43e-05	0.000181	CcSEcCtD
Fluoxetine—Fatigue—Timolol—glaucoma	6.42e-05	0.000181	CcSEcCtD
Fluoxetine—Pain—Timolol—glaucoma	6.37e-05	0.00018	CcSEcCtD
Fluoxetine—Diarrhoea—Betaxolol—glaucoma	6.24e-05	0.000176	CcSEcCtD
Fluoxetine—Nausea—Clonidine—glaucoma	6.22e-05	0.000176	CcSEcCtD
Fluoxetine—Feeling abnormal—Timolol—glaucoma	6.14e-05	0.000173	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Timolol—glaucoma	6.09e-05	0.000172	CcSEcCtD
Fluoxetine—Dizziness—Betaxolol—glaucoma	6.03e-05	0.00017	CcSEcCtD
Fluoxetine—Urticaria—Timolol—glaucoma	5.92e-05	0.000167	CcSEcCtD
Fluoxetine—Abdominal pain—Timolol—glaucoma	5.89e-05	0.000166	CcSEcCtD
Fluoxetine—Body temperature increased—Timolol—glaucoma	5.89e-05	0.000166	CcSEcCtD
Fluoxetine—Vomiting—Betaxolol—glaucoma	5.8e-05	0.000164	CcSEcCtD
Fluoxetine—Rash—Betaxolol—glaucoma	5.75e-05	0.000162	CcSEcCtD
Fluoxetine—Dermatitis—Betaxolol—glaucoma	5.74e-05	0.000162	CcSEcCtD
Fluoxetine—Headache—Betaxolol—glaucoma	5.71e-05	0.000161	CcSEcCtD
Fluoxetine—Hypersensitivity—Timolol—glaucoma	5.49e-05	0.000155	CcSEcCtD
Fluoxetine—Nausea—Betaxolol—glaucoma	5.42e-05	0.000153	CcSEcCtD
Fluoxetine—Asthenia—Timolol—glaucoma	5.34e-05	0.000151	CcSEcCtD
Fluoxetine—Pruritus—Timolol—glaucoma	5.27e-05	0.000149	CcSEcCtD
Fluoxetine—Diarrhoea—Timolol—glaucoma	5.1e-05	0.000144	CcSEcCtD
Fluoxetine—Dizziness—Timolol—glaucoma	4.93e-05	0.000139	CcSEcCtD
Fluoxetine—Vomiting—Timolol—glaucoma	4.74e-05	0.000134	CcSEcCtD
Fluoxetine—Rash—Timolol—glaucoma	4.7e-05	0.000133	CcSEcCtD
Fluoxetine—Dermatitis—Timolol—glaucoma	4.69e-05	0.000132	CcSEcCtD
Fluoxetine—Headache—Timolol—glaucoma	4.67e-05	0.000132	CcSEcCtD
Fluoxetine—Nausea—Timolol—glaucoma	4.42e-05	0.000125	CcSEcCtD
Fluoxetine—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	4.01e-05	0.00092	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.94e-05	0.000906	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.94e-05	0.000904	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.92e-05	0.0009	CbGpPWpGaD
Fluoxetine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.89e-05	0.000893	CbGpPWpGaD
Fluoxetine—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.83e-05	0.000881	CbGpPWpGaD
Fluoxetine—ALB—Platelet degranulation—VEGFA—glaucoma	3.8e-05	0.000874	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—TNF—glaucoma	3.8e-05	0.000873	CbGpPWpGaD
Fluoxetine—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.8e-05	0.000873	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.8e-05	0.000872	CbGpPWpGaD
Fluoxetine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.78e-05	0.000868	CbGpPWpGaD
Fluoxetine—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	3.75e-05	0.000861	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.66e-05	0.000841	CbGpPWpGaD
Fluoxetine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	3.62e-05	0.000832	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—OPN4—glaucoma	3.6e-05	0.000827	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CA5A—glaucoma	3.57e-05	0.000821	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NARFL—glaucoma	3.57e-05	0.000821	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—EDN1—glaucoma	3.55e-05	0.000816	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.55e-05	0.000815	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.55e-05	0.000815	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.54e-05	0.000813	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.37e-05	0.000773	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.35e-05	0.00077	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—TP53—glaucoma	3.35e-05	0.00077	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HEYL—glaucoma	3.35e-05	0.000768	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.25e-05	0.000746	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—PTGFR—glaucoma	3.24e-05	0.000744	CbGpPWpGaD
Fluoxetine—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.2e-05	0.000736	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—TP53—glaucoma	3.18e-05	0.000731	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.14e-05	0.00072	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—OPN4—glaucoma	3.13e-05	0.000718	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.11e-05	0.000713	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—C3—glaucoma	3.1e-05	0.000713	CbGpPWpGaD
Fluoxetine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.09e-05	0.00071	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—EDN1—glaucoma	3.09e-05	0.000709	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.06e-05	0.000703	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—TNF—glaucoma	3.02e-05	0.000694	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CA1—glaucoma	2.96e-05	0.000681	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	2.95e-05	0.000677	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HEYL—glaucoma	2.91e-05	0.000667	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CA1—glaucoma	2.9e-05	0.000665	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—TNF—glaucoma	2.89e-05	0.000663	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TGFB2—glaucoma	2.88e-05	0.000662	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CTSA—glaucoma	2.87e-05	0.000659	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.87e-05	0.000659	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—PTGFR—glaucoma	2.81e-05	0.000646	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CTSA—glaucoma	2.81e-05	0.000644	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—SMO—glaucoma	2.77e-05	0.000635	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NARFL—glaucoma	2.76e-05	0.000633	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CA5A—glaucoma	2.76e-05	0.000633	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CA2—glaucoma	2.71e-05	0.000623	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—C3—glaucoma	2.7e-05	0.000619	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.68e-05	0.000616	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—glaucoma	2.66e-05	0.000611	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CA2—glaucoma	2.65e-05	0.000609	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RPTOR—glaucoma	2.54e-05	0.000582	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.51e-05	0.000576	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CA1—glaucoma	2.49e-05	0.000573	CbGpPWpGaD
Fluoxetine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.47e-05	0.000568	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NCK2—glaucoma	2.46e-05	0.000564	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CTSA—glaucoma	2.42e-05	0.000555	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—SMO—glaucoma	2.4e-05	0.000552	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CA2—glaucoma	2.28e-05	0.000524	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CA1—glaucoma	2.24e-05	0.000514	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.23e-05	0.000512	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.23e-05	0.000512	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RPTOR—glaucoma	2.2e-05	0.000506	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CA1—glaucoma	2.19e-05	0.000502	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—SOD1—glaucoma	2.18e-05	0.000502	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CTSA—glaucoma	2.17e-05	0.000498	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NCK2—glaucoma	2.13e-05	0.00049	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CTSA—glaucoma	2.12e-05	0.000486	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.11e-05	0.000484	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HDAC9—glaucoma	2.09e-05	0.00048	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CA1—glaucoma	2.06e-05	0.000473	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CA2—glaucoma	2.05e-05	0.00047	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CA1—glaucoma	2.04e-05	0.000469	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—EDN1—glaucoma	2.01e-05	0.000461	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2e-05	0.00046	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2e-05	0.00046	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CA2—glaucoma	2e-05	0.000459	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2e-05	0.000459	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CTSA—glaucoma	2e-05	0.000458	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CTSA—glaucoma	1.98e-05	0.000454	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—TXN—glaucoma	1.91e-05	0.000439	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CA2—glaucoma	1.88e-05	0.000433	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CA2—glaucoma	1.87e-05	0.000429	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—TXN—glaucoma	1.87e-05	0.000429	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.83e-05	0.000419	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.83e-05	0.000419	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—EDN1—glaucoma	1.82e-05	0.000419	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HDAC9—glaucoma	1.81e-05	0.000416	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—C3—glaucoma	1.75e-05	0.000403	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CA1—glaucoma	1.75e-05	0.000401	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—EDN1—glaucoma	1.74e-05	0.000401	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CTSA—glaucoma	1.69e-05	0.000388	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.69e-05	0.000388	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—MMP1—glaucoma	1.67e-05	0.000382	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.66e-05	0.000382	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—SMO—glaucoma	1.63e-05	0.000375	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—TXN—glaucoma	1.61e-05	0.000369	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—CAV1—glaucoma	1.6e-05	0.000367	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CA2—glaucoma	1.6e-05	0.000367	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—C3—glaucoma	1.59e-05	0.000366	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—EDN1—glaucoma	1.58e-05	0.000364	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.56e-05	0.000358	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.56e-05	0.000358	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—C3—glaucoma	1.52e-05	0.00035	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—FN1—glaucoma	1.52e-05	0.000349	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NTRK2—glaucoma	1.49e-05	0.000343	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GSTT1—glaucoma	1.48e-05	0.00034	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.47e-05	0.000337	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.45e-05	0.000334	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GSTT1—glaucoma	1.45e-05	0.000332	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—TXN—glaucoma	1.44e-05	0.000331	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.42e-05	0.000327	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—SMO—glaucoma	1.42e-05	0.000326	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—TXN—glaucoma	1.41e-05	0.000324	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—C3—glaucoma	1.38e-05	0.000318	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CA1—glaucoma	1.35e-05	0.000309	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—TXN—glaucoma	1.33e-05	0.000305	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.32e-05	0.000302	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—TXN—glaucoma	1.32e-05	0.000302	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.3e-05	0.0003	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CTSA—glaucoma	1.3e-05	0.0003	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NTRK2—glaucoma	1.3e-05	0.000298	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NGFR—glaucoma	1.28e-05	0.000294	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.26e-05	0.000288	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GSTT1—glaucoma	1.25e-05	0.000286	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CA2—glaucoma	1.23e-05	0.000283	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NTRK1—glaucoma	1.22e-05	0.00028	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NOS3—glaucoma	1.21e-05	0.000277	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.2e-05	0.000276	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.19e-05	0.000273	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CYP1B1—glaucoma	1.18e-05	0.000271	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ABCA1—glaucoma	1.18e-05	0.000271	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ABCA1—glaucoma	1.15e-05	0.000265	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CYP1B1—glaucoma	1.15e-05	0.000265	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—TXN—glaucoma	1.12e-05	0.000258	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CDKN2B—glaucoma	1.12e-05	0.000258	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GSTT1—glaucoma	1.12e-05	0.000257	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NGFR—glaucoma	1.11e-05	0.000256	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GSTT1—glaucoma	1.09e-05	0.000251	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—EDN1—glaucoma	1.08e-05	0.000247	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NTRK1—glaucoma	1.06e-05	0.000243	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GSTT1—glaucoma	1.03e-05	0.000236	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.03e-05	0.000236	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GSTT1—glaucoma	1.02e-05	0.000234	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.02e-05	0.000234	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.01e-05	0.000231	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ABCA1—glaucoma	9.93e-06	0.000228	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CYP1B1—glaucoma	9.93e-06	0.000228	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NGF—glaucoma	9.9e-06	0.000227	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CDKN2B—glaucoma	9.75e-06	0.000224	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GSTM1—glaucoma	9.43e-06	0.000217	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—C3—glaucoma	9.41e-06	0.000216	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—EDN1—glaucoma	9.36e-06	0.000215	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GSTM1—glaucoma	9.22e-06	0.000212	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.02e-06	0.000207	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ABCA1—glaucoma	8.92e-06	0.000205	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CYP1B1—glaucoma	8.92e-06	0.000205	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—APOE—glaucoma	8.76e-06	0.000201	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GSTT1—glaucoma	8.72e-06	0.0002	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CYP1B1—glaucoma	8.7e-06	0.0002	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ABCA1—glaucoma	8.7e-06	0.0002	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—VEGFA—glaucoma	8.7e-06	0.0002	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CAV1—glaucoma	8.68e-06	0.000199	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—TXN—glaucoma	8.68e-06	0.000199	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NGF—glaucoma	8.6e-06	0.000197	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MTHFR—glaucoma	8.34e-06	0.000191	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—FN1—glaucoma	8.26e-06	0.00019	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.23e-06	0.000189	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ABCA1—glaucoma	8.2e-06	0.000188	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CYP1B1—glaucoma	8.2e-06	0.000188	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—C3—glaucoma	8.17e-06	0.000188	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—BAD—glaucoma	8.16e-06	0.000188	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MTHFR—glaucoma	8.15e-06	0.000187	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ABCA1—glaucoma	8.13e-06	0.000187	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CYP1B1—glaucoma	8.13e-06	0.000187	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GSTM1—glaucoma	7.94e-06	0.000182	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—APOE—glaucoma	7.76e-06	0.000178	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CAV1—glaucoma	7.69e-06	0.000177	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—APOE—glaucoma	7.61e-06	0.000175	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—APOE—glaucoma	7.59e-06	0.000174	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CAV1—glaucoma	7.54e-06	0.000173	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CAV1—glaucoma	7.52e-06	0.000173	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—FN1—glaucoma	7.18e-06	0.000165	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GSTM1—glaucoma	7.13e-06	0.000164	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—BAD—glaucoma	7.09e-06	0.000163	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.03e-06	0.000161	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MTHFR—glaucoma	7.02e-06	0.000161	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GSTM1—glaucoma	6.96e-06	0.00016	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CYP1B1—glaucoma	6.95e-06	0.00016	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ABCA1—glaucoma	6.95e-06	0.00016	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GSTT1—glaucoma	6.73e-06	0.000155	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—TP53—glaucoma	6.57e-06	0.000151	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NOS3—glaucoma	6.56e-06	0.000151	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GSTM1—glaucoma	6.56e-06	0.000151	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—APOE—glaucoma	6.53e-06	0.00015	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GSTM1—glaucoma	6.5e-06	0.000149	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CAV1—glaucoma	6.47e-06	0.000149	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MTHFR—glaucoma	6.3e-06	0.000145	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MTHFR—glaucoma	6.15e-06	0.000141	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—APOE—glaucoma	5.86e-06	0.000135	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—NOS3—glaucoma	5.81e-06	0.000134	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CAV1—glaucoma	5.81e-06	0.000133	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MTHFR—glaucoma	5.79e-06	0.000133	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MTHFR—glaucoma	5.74e-06	0.000132	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—APOE—glaucoma	5.72e-06	0.000131	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NOS3—glaucoma	5.7e-06	0.000131	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CDKN1B—glaucoma	5.69e-06	0.000131	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—NOS3—glaucoma	5.68e-06	0.000131	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CAV1—glaucoma	5.67e-06	0.00013	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GSTM1—glaucoma	5.55e-06	0.000128	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—APOE—glaucoma	5.39e-06	0.000124	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CYP1B1—glaucoma	5.36e-06	0.000123	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ABCA1—glaucoma	5.36e-06	0.000123	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—APOE—glaucoma	5.35e-06	0.000123	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CAV1—glaucoma	5.34e-06	0.000123	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PTGS2—glaucoma	5.32e-06	0.000122	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CAV1—glaucoma	5.3e-06	0.000122	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MMP9—glaucoma	5.27e-06	0.000121	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PTGS2—glaucoma	5.2e-06	0.000119	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CDKN1B—glaucoma	4.94e-06	0.000113	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MTHFR—glaucoma	4.91e-06	0.000113	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—NOS3—glaucoma	4.89e-06	0.000112	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—VEGFA—glaucoma	4.73e-06	0.000109	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MMP9—glaucoma	4.57e-06	0.000105	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—APOE—glaucoma	4.57e-06	0.000105	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CAV1—glaucoma	4.53e-06	0.000104	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PTGS2—glaucoma	4.48e-06	0.000103	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NOS3—glaucoma	4.39e-06	0.000101	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NOS3—glaucoma	4.29e-06	9.85e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GSTM1—glaucoma	4.29e-06	9.85e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—VEGFA—glaucoma	4.11e-06	9.43e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NOS3—glaucoma	4.04e-06	9.28e-05	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PTGS2—glaucoma	4.02e-06	9.23e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NOS3—glaucoma	4.01e-06	9.2e-05	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PTGS2—glaucoma	3.92e-06	9.01e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MTHFR—glaucoma	3.79e-06	8.7e-05	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PTGS2—glaucoma	3.7e-06	8.49e-05	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PTGS2—glaucoma	3.66e-06	8.42e-05	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TP53—glaucoma	3.57e-06	8.21e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—APOE—glaucoma	3.53e-06	8.1e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CAV1—glaucoma	3.49e-06	8.03e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NOS3—glaucoma	3.42e-06	7.86e-05	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PTGS2—glaucoma	3.13e-06	7.19e-05	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TP53—glaucoma	3.1e-06	7.13e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NOS3—glaucoma	2.64e-06	6.07e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PTGS2—glaucoma	2.42e-06	5.55e-05	CbGpPWpGaD
